Skip to main
LFST

LFST Stock Forecast & Price Target

LFST Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

LifeStance Health Gr is a solid investment due to their strong growth potential, low customer acquisition costs, and consistent focus on expanding services and investing in technology. While there is potential risk from competition and economic factors, the company's stable rate environment and strong revenue stream provide a solid foundation for continued success.

Bears say

LifeStance Health Gr is facing several challenges that are likely to have a negative impact on its financial performance and stock price. These challenges include government policy uncertainty surrounding healthcare, potential de-emphasis on behavioral health coverage and reimbursement, and potential decreases in the number of insured or unemployed individuals. These risks could lead to a decrease in demand for LifeStance's services and negatively impact its revenue and growth prospects. The company also faces risks related to its young, high-growth market, potential cybersecurity threats, and competition within the telehealth industry. While the company has recently turned EBITDA-positive and has a strong demand environment, these risks may outweigh these positives and hinder the company's ability to achieve its mid-teens growth algorithm.

LFST has been analyzed by 8 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of LifeStance Health Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About LifeStance Health Group (LFST) Forecast

Analysts have given LFST a Buy based on their latest research and market trends.

According to 8 analysts, LFST has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

LifeStance Health Group (LFST)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.